{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7345,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-341d-707d-8f10-e094a3d9771c",
      "docSlug": "c0c2a81b97260bf20014943df2470872",
      "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a sequential clinical trial process.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/33",
      "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
      "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-341d-707d-8f10-e094a3d9771c",
      "docSlug": "c0c2a81b97260bf20014943df2470872",
      "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/34",
      "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
      "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-341d-707d-8f10-e094a3d9771c",
      "docSlug": "c0c2a81b97260bf20014943df2470872",
      "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide highlights the team's pedigree by listing past company affiliations for each executive and providing a collective logo grid at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/35",
      "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
      "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 35,
          "from": 35,
          "beatId": "493482e1-fe58-4e6b-904e-a76e5407321c",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "The team is introduced on page 35.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-341d-707d-8f10-e094a3d9771c",
      "docSlug": "c0c2a81b97260bf20014943df2470872",
      "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "appendix",
      "function": "other",
      "notes": "The slide uses a timeline framework to map patent coverage and exclusivity periods across two main product categories.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/36",
      "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
      "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-341d-707d-8f10-e094a3d9771c",
      "docSlug": "c0c2a81b97260bf20014943df2470872",
      "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "appendix_data",
      "function": "summarize",
      "notes": "The slide provides a snapshot of the company's financial health as of late 2023.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/37",
      "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
      "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-341d-707d-8f10-e094a3d9771c",
      "docSlug": "c0c2a81b97260bf20014943df2470872",
      "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "timeline",
      "function": "plan_implementation",
      "notes": "The slide uses a grouped list format to present clinical trial milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/38",
      "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
      "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-341d-707d-8f10-e094a3d9771c",
      "docSlug": "c0c2a81b97260bf20014943df2470872",
      "documentTitle": "Equillium | Investor Presentation Deck | 39 slides",
      "authorId": "equillium",
      "authorName": "Equillium",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/39",
      "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c",
      "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The slide uses a high-quality lifestyle photo to establish an emotional connection to the company's mission.",
      "imagePath": "https://imgproxy.kitesheet.com/_tPgrK_Bubg0Cl3X1kUhvplWefDZEQ2MUrZr4myiR0o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/1",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Introduction to Erasca and RAS/MAPK pathway",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": "https://imgproxy.kitesheet.com/pVGafVjvfmH1i7SimNGOMoyeD-77fQ00u5FNCymf1GY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/foEkZE3voArwZUdagShOmfjb7OG7rqYVTbYbe6XYWE8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/6rNR6ztYVfOG1e4ov5YZxso-Z5caY6BP9sO6EC8mS8Y/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLnBuZw"
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/2",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Introduction to Erasca and RAS/MAPK pathway",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "mission",
      "function": "inspire_vision",
      "notes": "The slide uses a hub-and-spoke diagram to connect the company name to three core pillars: leadership, portfolio, and financials.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/3",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Introduction to Erasca and RAS/MAPK pathway",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "team_bio",
      "function": "other",
      "notes": "SAB stands for Scientific Advisory Board.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/4",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Introduction to Erasca and RAS/MAPK pathway",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The table uses a heatmap-style color coding where red indicates existing targeted therapy markets and teal indicates blue ocean opportunities.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/5",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-5",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3",
          "evidence": "Slides 5-10 introduce the pathway and pipeline",
          "position": 0,
          "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 1,
          "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Introduction to Erasca and RAS/MAPK pathway",
          "beatSlug": "rags-to-riches-humble-origins",
          "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Setup",
          "parentBeatSlug": "setup"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for the company's therapeutic approach.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/6",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-6",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3",
          "evidence": "Slides 5-10 introduce the pathway and pipeline",
          "position": 0,
          "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style visualization for clinical trial progress.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/7",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-7",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3",
          "evidence": "Slides 5-10 introduce the pathway and pipeline",
          "position": 0,
          "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological process diagram to map drug assets to specific protein targets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/8",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-8",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3",
          "evidence": "Slides 5-10 introduce the pathway and pipeline",
          "position": 0,
          "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a matrix structure to map indications to benchmarks, specific drug regimens, and trial names, with a footer detailing active clinical trial collaboration and supply agreements (CTCSAs).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/9",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-9",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3",
          "evidence": "Slides 5-10 introduce the pathway and pipeline",
          "position": 0,
          "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The chart uses a stacked bar approach to represent US and Europe patient counts per program, with a total sum at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/10",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-10",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3",
          "evidence": "Slides 5-10 introduce the pathway and pipeline",
          "position": 0,
          "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide combines a biological pathway diagram (left) with a quantitative market sizing table (right).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/11",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The kinome tree is a standard visualization for kinase selectivity.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/12",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate proof of concept.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/13",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes two waterfall plots comparing patient responses; source cited as Novartis materials.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/14",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/15",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-15",
      "loopMatches": [
        {
          "to": 20,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f",
          "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline",
          "position": 1,
          "objective": "Highlight the cost of not addressing unmet needs in cancer treatment",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 15,
          "from": 6,
          "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Challenges in current cancer treatment and unmet needs",
          "beatSlug": "rags-to-riches-early-struggles",
          "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Waterfall plot shows individual patient responses; table compares efficacy metrics against Dacarbazine and Binimetinib.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/16",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-16",
      "loopMatches": [
        {
          "to": 20,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f",
          "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline",
          "position": 1,
          "objective": "Highlight the cost of not addressing unmet needs in cancer treatment",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "The slide uses a before-after-framing approach to demonstrate clinical efficacy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/17",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-17",
      "loopMatches": [
        {
          "to": 20,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f",
          "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline",
          "position": 1,
          "objective": "Highlight the cost of not addressing unmet needs in cancer treatment",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a swimmer plot to visualize individual patient treatment duration and response status.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/18",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-18",
      "loopMatches": [
        {
          "to": 20,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f",
          "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline",
          "position": 1,
          "objective": "Highlight the cost of not addressing unmet needs in cancer treatment",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a summary calculation (13/39 = 33.3% ORR) to aggregate results across two different clinical phases.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/19",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-19",
      "loopMatches": [
        {
          "to": 20,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f",
          "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline",
          "position": 1,
          "objective": "Highlight the cost of not addressing unmet needs in cancer treatment",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Swimmer plot showing individual patient treatment duration and response status (NE, PD, PR, SD).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/20",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-20",
      "loopMatches": [
        {
          "to": 20,
          "from": 15,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f",
          "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline",
          "position": 1,
          "objective": "Highlight the cost of not addressing unmet needs in cancer treatment",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The diagram uses a flow-chart structure to categorize patient outcomes (off treatment vs on treatment) and further breaks down the 'on treatment' group into SDs and PRs with specific progression delay metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/21",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "traction",
      "function": "analyze_data",
      "notes": "The chart displays adverse events occurring in >=10% of patients (n=15).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/22",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9",
      "docSlug": "e7da6c89bd00edfe5ee10f12333167ff",
      "documentTitle": "Erasca | Investor Presentation Deck | 56 slides",
      "authorId": "erasca",
      "authorName": "Erasca",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "CoC = Cost of Care (or standard of care context); FIH = First-in-Human; PTS = Probability of Technical Success; CDP = Clinical Development Plan.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/23",
      "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9",
      "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 42,
          "from": 16,
          "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Erasca's pipeline and clinical data",
          "beatSlug": "rags-to-riches-rising-success",
          "evidence": "Slides 16-42 present Erasca's pipeline and clinical data",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}